Virtual screening for small molecule pathway regulators by image profile matching

Identifying chemical regulators of biological pathways is a time-consuming bottleneck in developing therapeutics and research compounds. Typically, thousands to millions of candidate small molecules are tested in target-based biochemical screens or phenotypic cell-based screens, both expensive experiments customized to each disease. Here, our uncustomized, virtual profile-based screening approach instead identifies compounds that match to pathways based on phenotypic information in public cell image data, created using the Cell Painting assay. Our straightforward correlation-based computational strategy retrospectively uncovered the expected, known small molecule regulators for 32% of positive-control gene queries. In prospective, discovery mode, we efficiently identified new compounds related to three query genes, and validated them in subsequent gene-relevant assays, including compounds that phenocopy or pheno-oppose YAP1 overexpression and kill a Yap1-dependent sarcoma cell line. This image profile-based approach could replace many customized labor- and resource-intensive screens and accelerate the discovery of biologically and therapeutically useful compounds. One sentence summary If a genetic perturbation impacts cell morphology, a computational query can reveal compounds whose morphology “matches”.

[1]  V. Rotter,et al.  Visual barcodes for clonal-multiplexing of live microscopy-based assays , 2022, Nature Communications.

[2]  U. Sauer,et al.  High‐throughput metabolomics predicts drug–target relationships for eukaryotic proteins , 2022, Molecular systems biology.

[3]  Anne E Carpenter,et al.  Three million images and morphological profiles of cells treated with matched chemical and genetic perturbations , 2022, bioRxiv.

[4]  Anne E Carpenter,et al.  Predicting compound activity from phenotypic profiles and chemical structures , 2020, bioRxiv.

[5]  Anne E Carpenter,et al.  High-Dimensional Gene Expression and Morphology Profiles of Cells across 28,000 Genetic and Chemical Perturbations , 2021, bioRxiv.

[6]  Juan C. Caicedo,et al.  Image-based cell phenotyping with deep learning. , 2021, Current opinion in chemical biology.

[7]  K. Guan,et al.  Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma , 2021, Molecular Cancer Therapeutics.

[8]  John C. Dawson,et al.  High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need. , 2021, Cell chemical biology.

[9]  Andreas Bender,et al.  Comparison of Chemical Structure and Cell Morphology Information for Multitask Bioactivity Predictions , 2021, J. Chem. Inf. Model..

[10]  N. Knoers,et al.  Drug Repurposing for Rare Diseases. , 2021, Trends in pharmacological sciences.

[11]  Anne E Carpenter,et al.  Image-based profiling for drug discovery: due for a machine-learning upgrade? , 2020, Nature Reviews Drug Discovery.

[12]  Jongmin Park,et al.  Recent advances in identifying protein targets in drug discovery. , 2020, Cell chemical biology.

[13]  Kara Dolinski,et al.  The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions , 2020, Protein science : a publication of the Protein Society.

[14]  R. Kafri,et al.  Visual Barcodes for Multiplexing Live Microscopy-Based Assays , 2020 .

[15]  H. Waldmann,et al.  Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets , 2020, Chembiochem : a European journal of chemical biology.

[16]  K. Guan,et al.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine , 2020, Nature Reviews Drug Discovery.

[17]  J. Halling,et al.  PGC-1α-mediated regulation of mitochondrial function and physiological implications. , 2020, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[18]  M. Mckee,et al.  Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. , 2020, JAMA.

[19]  E. de Nadal,et al.  The p38 Pathway: From Biology to Cancer Therapy , 2020, International journal of molecular sciences.

[20]  H. Waldmann,et al.  Phenotyping Reveals Targets of a Pseudo‐Natural‐Product Autophagy Inhibitor , 2020, Angewandte Chemie.

[21]  G. Schneider,et al.  Rethinking drug design in the artificial intelligence era , 2019, Nature Reviews Drug Discovery.

[22]  Xin Liu,et al.  All-Assay-Max2 pQSAR: Activity Predictions as Accurate as Four-Concentration IC50s for 8558 Novartis Assays , 2019, J. Chem. Inf. Model..

[23]  A. Lin,et al.  Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials , 2019, Science Translational Medicine.

[24]  Anne E Carpenter,et al.  A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport , 2019, Cell reports.

[25]  Asher Mullard Machine learning brings cell imaging promises into focus , 2019, Nature Reviews Drug Discovery.

[26]  L. Kiessling,et al.  Angiomotin Regulates YAP Localization during Neural Differentiation of Human Pluripotent Stem Cells , 2019, Stem cell reports.

[27]  Parantu K. Shah,et al.  Applications of machine learning in drug discovery and development , 2019, Nature Reviews Drug Discovery.

[28]  O. Spjuth,et al.  Evaluation of Gene Expression and Phenotypic Profiling Data as Quantitative Descriptors for Predicting Drug Targets and Mechanisms of Action , 2019, bioRxiv.

[29]  Ewgenij Proschak,et al.  Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds. , 2018, Journal of medicinal chemistry.

[30]  Anne E Carpenter,et al.  Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery. , 2018, Cell chemical biology.

[31]  Mousheng Xu,et al.  YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. , 2018, Cancer research.

[32]  A. Nierenberg,et al.  Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders , 2018, Biological Psychiatry.

[33]  Jen Q. Pan,et al.  Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia , 2018, Science Translational Medicine.

[34]  Ravi Iyengar,et al.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.

[35]  Heiner Koch,et al.  The target landscape of clinical kinase drugs , 2017, Science.

[36]  Yongbin Wei,et al.  Industry Perspective , 2017, IEEE Wirel. Commun..

[37]  M. Prunotto,et al.  Opportunities and challenges in phenotypic drug discovery: an industry perspective , 2017, Nature Reviews Drug Discovery.

[38]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[39]  Larry Wasserman,et al.  Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length , 2017, bioRxiv.

[40]  Anne E Carpenter,et al.  Systematic morphological profiling of human gene and allele function via Cell Painting , 2017, eLife.

[41]  Geet Duggal,et al.  Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.

[42]  Rob Patro,et al.  Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.

[43]  Anne E Carpenter,et al.  A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay , 2017, GigaScience.

[44]  Ernest Turro,et al.  ontologyX: a suite of R packages for working with ontological data , 2016, Bioinform..

[45]  Juliann Shih,et al.  Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer. , 2017, Cancer research.

[46]  P. Puigserver,et al.  PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors. , 2016, Trends in cancer.

[47]  John Quackenbush,et al.  Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. , 2016, JCI insight.

[48]  Anne E Carpenter,et al.  Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes , 2016, Nature Protocols.

[49]  E. Nishida,et al.  Src family kinases suppress differentiation of brown adipocytes and browning of white adipocytes , 2016, Genes to cells : devoted to molecular & cellular mechanisms.

[50]  Satoshi O. Suzuki,et al.  Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice , 2015, Proceedings of the National Academy of Sciences.

[51]  Sharon Gerecht,et al.  Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis , 2015, Proceedings of the National Academy of Sciences.

[52]  Károly Héberger,et al.  Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? , 2015, Journal of Cheminformatics.

[53]  Sean P. Palecek,et al.  Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification , 2014, Proceedings of the National Academy of Sciences.

[54]  Anne E Carpenter,et al.  Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling , 2014, Proceedings of the National Academy of Sciences.

[55]  Jacob J. Hughey,et al.  High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells , 2014, Cell.

[56]  Anne E Carpenter,et al.  Multiplex Cytological Profiling Assay to Measure Diverse Cellular States , 2013, PloS one.

[57]  Joshua M. Stuart,et al.  Large-scale cytological profiling for functional analysis of bioactive compounds. , 2013, Molecular bioSystems.

[58]  Mark E Bunnage,et al.  Target validation using chemical probes. , 2013, Nature chemical biology.

[59]  Joshua M. Stuart,et al.  "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening. , 2013, Chemistry & biology.

[60]  H. Osada,et al.  Morphobase, an encyclopedic cell morphology database, and its use for drug target identification. , 2012, Chemistry & biology.

[61]  Carol A. Mulrooney,et al.  Build/couple/pair strategy for the synthesis of stereochemically diverse macrolactams via head-to-tail cyclization. , 2012, ACS combinatorial science.

[62]  Mindy I. Davis,et al.  Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.

[63]  E. Lawlor,et al.  BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma , 2011, Oncogene.

[64]  Nathan T. Ross,et al.  An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.

[65]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[66]  M. Barbacid,et al.  Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival , 2010, The EMBO journal.

[67]  Leah M. Williams,et al.  Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190. , 2009, BMB reports.

[68]  Thomas L Schwarz,et al.  Imaging axonal transport of mitochondria. , 2009, Methods in enzymology.

[69]  C. Chi,et al.  PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells. , 2009, Anticancer research.

[70]  R. Jaenisch,et al.  YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.

[71]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[72]  B. Spiegelman,et al.  Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. , 2006, Endocrine reviews.

[73]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[75]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[76]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[77]  S. Haggarty,et al.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. , 1999, Science.

[78]  E. Bengal,et al.  p38 Mitogen-activated Protein Kinase Pathway Promotes Skeletal Muscle Differentiation , 1999, The Journal of Biological Chemistry.

[79]  R. Derynck,et al.  The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.